Stock Earnings

Question 1

What are Pacira Biosciences Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Pacira Biosciences Inc has a total asset of $1,553, Net loss of $-99

Question 2

What are the key financial ratios for PCRX?

Accepted Answer

Pacira Biosciences Inc's Current ratio is 2, has a Net margin is -14.14, sales per share of $15.13.

Question 3

How is Pacira Biosciences Inc's revenue broken down by segment or geography?

Accepted Answer

Pacira Biosciences Inc largest revenue segment is Non-opioid Pain Management and Regenerative Health Solutions, at a revenue of 674,978,000 in the most earnings release.For geography, United States, European Union, United Kingdom and Canada is the primary market for Pacira Biosciences Inc, at a revenue of 674,978,000.

Question 4

Is Pacira Biosciences Inc profitable?

Accepted Answer

no, according to the latest financial statements, Pacira Biosciences Inc has a net loss of $-99

Question 5

Does Pacira Biosciences Inc have any liabilities?

Accepted Answer

yes, Pacira Biosciences Inc has liability of 775

Question 6

How many outstanding shares for Pacira Biosciences Inc?

Accepted Answer

Pacira Biosciences Inc has a total outstanding shares of 46.24

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	716	700	674	666	541	429
Revenue Growth (YoY)	-17%	4%	1%	23%	26%	2%
Cost of Revenue	149	170	184	199	140	117
Gross Profit	567	530	490	467	401	312
Selling, General & Admin	346	294	269	254	199	184
Research & Development	101	81	76	84	55	59
Operating Expenses	503	428	399	396	268	251
Other Non Operating Income (Expenses)	4	0	0	-11	-2	2
Pretax Income	41	-63	61	13	56	20
Income Tax Expense	20	36	19	-2	14	-125
Net Income	21	-99	41	15	42	145
Net Income Growth	-126%	-341%	173%	-64%	-71%	-1,418%
Shares Outstanding (Diluted)	44.45	46.24	51.97	46.5	45.6	43.7
Shares Change (YoY)	-4%	-11%	12%	2%	4%	5%
EPS (Diluted)	0.46	-2.15	0.8	0.34	0.92	3.33
EPS Growth	-126%	-369%	135%	-63%	-72%	-1,333%
Free Cash Flow	124	178	139	115	79	39
Free Cash Flow Per Share	2.78	3.84	2.67	2.47	1.73	0.89
Gross Margin	79.18%	75.71%	72.7%	70.12%	74.12%	72.72%
Operating Margin	8.79%	14.57%	13.35%	10.51%	24.39%	13.98%
Profit Margin	2.93%	-14.14%	6.08%	2.25%	7.76%	33.79%
Free Cash Flow Margin	17.31%	25.42%	20.62%	17.26%	14.6%	9.09%
EBITDA	120	159	147	127	145	67
EBITDA Margin	16.75%	22.71%	21.81%	19.06%	26.8%	15.61%
D&A For EBITDA	57	57	57	57	13	7
EBIT	63	102	90	70	132	60
EBIT Margin	8.79%	14.57%	13.35%	10.51%	24.39%	13.98%
Effective Tax Rate	48.78%	-57.14%	31.14%	-15.38%	25%	-625%

Pacira Biosciences Inc (PCRX) Price

PCRX Stock Price Chart

PCRX Income

Follow-Up Questions